{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T07:11:47Z","timestamp":1718089907783},"reference-count":26,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":95,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Virol."],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1002\/jmv.24006","type":"journal-article","created":{"date-parts":[[2015,5,29]],"date-time":"2015-05-29T16:10:50Z","timestamp":1432915850000},"page":"1527-1531","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence and types of drug-resistant variants in Chinese patients with acute hepatitis B"],"prefix":"10.1002","volume":"87","author":[{"given":"Feifei","family":"Su","sequence":"first","affiliation":[{"name":"Department of Infection Diseases; Wenzhou Central Hospital; Wenzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianyi","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Infection Diseases; Wenzhou Central Hospital; Wenzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoufeng","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Infection Diseases; Wenzhou Central Hospital; Wenzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangao","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Infection Diseases; Wenzhou Central Hospital; Wenzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoya","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Infection Diseases; Wenzhou Central Hospital; Wenzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongye","family":"Ning","sequence":"additional","affiliation":[{"name":"Department of Infection Diseases; Wenzhou Central Hospital; Wenzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhua","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Infection Diseases; Wenzhou Central Hospital; Wenzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohe","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Infection Diseases; Wenzhou Central Hospital; Wenzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,5,29]]},"reference":[{"key":"10.1002\/jmv.24006-BIB0001|jmv24006-cit-0001","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/hep.510270628","article-title":"Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group","volume":"27","author":"Allen","year":"1998","journal-title":"Hepatology"},{"key":"10.1002\/jmv.24006-BIB0002|jmv24006-cit-0002","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0016-5085(03)00939-9","article-title":"Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase","volume":"125","author":"Angus","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1002\/jmv.24006-BIB0003|jmv24006-cit-0003","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2012.09.014","article-title":"Evaluation of anti-HBV drug resistant mutations among patients with acute symptomatic hepatitis B in the United States","volume":"58","author":"Baxa","year":"2013","journal-title":"J Hepatol"},{"key":"10.1002\/jmv.24006-BIB0004|jmv24006-cit-0004","first-page":"6","article-title":"Management scheme of diagnostic and therapy criteria of viral hepatitis","volume":"8","author":"Chinese Society of Infectious Diseases PCSoH","year":"2000","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"10.1002\/jmv.24006-BIB0005|jmv24006-cit-0005","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/hep.21422","article-title":"Entecavir resistance is rare in nucleoside naive patients with hepatitis B","volume":"44","author":"Colonno","year":"2006","journal-title":"Hepatology"},{"key":"10.1002\/jmv.24006-BIB0006|jmv24006-cit-0006","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jinf.2013.06.006","article-title":"Lamivudine-resistant HBV strain rtM204V\/I in acute hepatitis B","volume":"67","author":"Coppola","year":"2013","journal-title":"J Infect"},{"key":"10.1002\/jmv.24006-BIB0007|jmv24006-cit-0007","doi-asserted-by":"crossref","first-page":"11833","DOI":"10.1128\/JVI.77.21.11833-11841.2003","article-title":"The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro","volume":"77","author":"Delaney","year":"2003","journal-title":"J Virol"},{"key":"10.1002\/jmv.24006-BIB0008|jmv24006-cit-0008","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.coviro.2013.08.006","article-title":"Hepatitis B antivirals and resistance","volume":"3","author":"Devi","year":"2013","journal-title":"Curr Opin Virol"},{"key":"10.1002\/jmv.24006-BIB0009|jmv24006-cit-0009","doi-asserted-by":"crossref","first-page":"S174","DOI":"10.1002\/hep.22900","article-title":"Antiviral resistance and hepatitis B therapy","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"key":"10.1002\/jmv.24006-BIB0010|jmv24006-cit-0010","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/jmv.20824","article-title":"Comparison of hepatitis B virus subgenotypes in patients with acute and chronic hepatitis B and absence of lamivudine-resistant strains in acute hepatitis B in Japan","volume":"79","author":"Hayashi","year":"2007","journal-title":"J Med Virol"},{"key":"10.1002\/jmv.24006-BIB0011|jmv24006-cit-0011","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/liv.12081","article-title":"Management of acute hepatitis B and reactivation of hepatitis B","volume":"33","author":"Jindal","year":"2013","journal-title":"Liver Int"},{"key":"10.1002\/jmv.24006-BIB0012|jmv24006-cit-0012","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.gastro.2005.05.053","article-title":"A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B","volume":"129","author":"Lai","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1002\/jmv.24006-BIB0013|jmv24006-cit-0013","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1053\/j.gastro.2008.10.026","article-title":"2-Year GLOBE trial results: Telbivudine Is superior to lamivudine in patients with chronic hepatitis B","volume":"136","author":"Liaw","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1002\/jmv.24006-BIB0014|jmv24006-cit-0014","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1111\/j.1365-2893.2010.01360.x","article-title":"Genotypic resistance profile of hepatitis B virus (HBV) in a large cohort of nucleos(t)ide analogue-experienced Chinese patients with chronic HBV infection","volume":"18","author":"Liu","year":"2011","journal-title":"J Viral Hepat"},{"key":"10.1002\/jmv.24006-BIB0015|jmv24006-cit-0015","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1002\/jmv.23369","article-title":"Clinical characteristics and chronicity of acute hepatitis B induced by lamivudine-resistant strains","volume":"84","author":"Luo","year":"2012","journal-title":"J Med Virol"},{"key":"10.1002\/jmv.24006-BIB0016|jmv24006-cit-0016","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1128\/JCM.02477-05","article-title":"Detection of rtN236T and rtA181V\/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2)","volume":"44","author":"Osiowy","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1002\/jmv.24006-BIB0017|jmv24006-cit-0017","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: Management of chronic hepatitis B virus infection","volume":"57","author":"Papatheodoridis","year":"2012","journal-title":"J Hepatol"},{"key":"10.1002\/jmv.24006-BIB0018|jmv24006-cit-0018","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1053\/j.gastro.2007.11.036","article-title":"Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: Recommendations for a standardized approach","volume":"134","author":"Pawlotsky","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1002\/jmv.24006-BIB0019|jmv24006-cit-0019","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1177\/135965350701200309","article-title":"In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agents","volume":"12","author":"Qi","year":"2007","journal-title":"Antivir Ther"},{"key":"10.1002\/jmv.24006-BIB0020|jmv24006-cit-0020","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJMoa051214","article-title":"Variant of hepatitis B virus with primary resistance to adefovir","volume":"354","author":"Schildgen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1002\/jmv.24006-BIB0021|jmv24006-cit-0021","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/jmv.23608","article-title":"Hepatitis B virus reverse transcriptase mutations in treatment Naive chronic hepatitis B patients","volume":"85","author":"Singla","year":"2013","journal-title":"J Med Virol"},{"key":"10.1002\/jmv.24006-BIB0022|jmv24006-cit-0022","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1128\/AAC.48.9.3498-3507.2004","article-title":"Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine","volume":"48","author":"Tenney","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jmv.24006-BIB0023|jmv24006-cit-0023","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1128\/AAC.00833-06","article-title":"Two-year assessment of entecavir resistance in Lamivudine-refractory hepatitis B virus patients reveals different clinical outcomes depending on the resistance substitutions present","volume":"51","author":"Tenney","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jmv.24006-BIB0024|jmv24006-cit-0024","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1128\/AAC.01499-06","article-title":"The L80I substitution in the reverse transcriptase domain of the hepatitis B virus polymerase is associated with lamivudine resistance and enhanced viral replication in vitro","volume":"51","author":"Warner","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jmv.24006-BIB0025|jmv24006-cit-0025","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jcv.2010.05.010","article-title":"Acute hepatitis B infection associated with drug-resistant hepatitis B virus","volume":"48","author":"Xu","year":"2010","journal-title":"J Clin Virol"},{"key":"10.1002\/jmv.24006-BIB0026|jmv24006-cit-0026","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2009.08.063","article-title":"Hepatitis B virus resistance to nucleos(t)ide analogues","volume":"137","author":"Zoulim","year":"2009","journal-title":"Gastroenterology"}],"container-title":["Journal of Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjmv.24006","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/jmv.24006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T02:07:52Z","timestamp":1652148472000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jmv.24006"}},"subtitle":["Prevalence of HBV Variants in Acute Hepatitis B"],"short-title":[],"issued":{"date-parts":[[2015,5,29]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"URL":"https:\/\/doi.org\/10.1002\/jmv.24006","archive":["Portico"],"relation":{},"ISSN":["0146-6615"],"issn-type":[{"value":"0146-6615","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5,29]]}}}